| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 12 | 41 |
 |  Saxol Neuroprotecting Patient's Future Saxol, newborn company develops innovative compounds able to fight and/or to prevent peripheral neuropathies, including Diabetes peripheral neuropathies, Immuno and Chemotherapy-Induced Peripheral Neuropathies (CIPN). Based on IAB research on Carbazole structure (Lafanechère Team) and with the support of Linksium, we plan to bring to patients, new neuroprotective drugs to answers current Unmet Medical needs CARBA1, our lead compound has neuroprotective activity through a mechanism of regulation and reactivation of energy production at the cellular level. We plan first to develop Carba1 for CIPN Unmet Medical Need and to enlarge after to Diabetes Peripheral Neuropathy DPN and other … Type: | 4 | 2 |
 | Inneolab Designs products that meet the expectations of users and reveal the values of the company. Are you responsible for the product offer, do you want to improve sales and limit the risk of commercial failure? An essential point A product can be functional, marketed at a coherent price compared to its market and yet sell poorly or receive poor opinions. Beyond the function, the product must meet customer expectations. If he does not make you want, if he does not inspire confidence, if he does not respond to unsubstanced unspokenness than the function, buyers will move towards competition. Two errors … Type: | 9 | 2 |
 |  Wespran Shaping the future of green biotech Wespran is a French climate deeptech startup specializing in synthetic biology and proteins. It is developing a turnkey biomimetic technology to upcycle industrial CO2 emissions into valuable products, starting with green methanol. At the forefront of biochemistry, physics, and bioinformatics, Wespran's clean biotechnology, FREED (Free Reactions using Enzymatic Electrocatalysis for Decarbonization), harnesses engineered enzymes. This innovative solution offers decarbonization as a service. By leveraging nature's power, Wespran helps industries reduce their carbon footprint while generating substantial profit. Target sectors include refineries, steel plants, chemical manufacturers, incinerators, cement factories, and thermal power plants. With a … Type: | 1 | 2 |
 | Cyprio Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver … Type: | 3 | 2 |
 | SYNAXYS Accelerate drug development for neurological diseases SYNAXYS is French biotech specialized in the characterization of the response of the nervous system for nutraceutic, pharmaceutic and veterinary applications. We offer a complete range of R&D services to support drug development, from defining the dose effects in a human model, to identify biological targets and action mechanism, acute and chronic toxicity, or comparison to established treatments. Our field of application: - Drug positioning - Therapeutic evaluation in a diease model - Neuro-oncology - Data generation for IA modeling Neuro-engineering, Neuronal diseases modeling, Neuro-oncology, Autism, Alzheimer disease, and Glioblastoma Type: | 2 | 2 |
 | CARLA Biotherapeutics First In Class Adoptive Cell Therapies to Cure Patients Carla Biotherapeutics is a Biotech company developing first-in-class adoptive cell therapies tailored to treat diseases with high unmet medical need with a first focus on aggressive life-threatening cancer. Carla Biotherapeutics is founded by a team of seasoned clinicians, cell therapy scientists and biotech professional in Besançon, France with access to a world-class and unique cell-therapy platform. Carla Biotherapeutics’ ambition is to build and develop a pipeline of immunotherapies based on a fully integrated cell therapy platform to discover ena develop adoptive cell therapies tailored to each indication. Type: | 11 | 2 |
 | NEVEZYNE Nevezyne develops her own protein expression systems and offers her expertise in the expression of recombinant proteins, for research programs, for animal health diagnosis, human Protein expression, badvirus system, protein purification, and bacterial system Type: | 4 | 3 |
 | VistaCare Medical For a good wound bed preparation VistaCare Medical develops, manufactures and distributes medical devices for the treatment of complex wounds, whether acute or chronic. We aim to contribute with health professionals to improve the lives of patients suffering from complex wounds that are difficult to treat with standard therapies. Our current product on the market VistaCare One is showing an improvement in the debridement and vascularization steps of wound healing process making it an ideal wound bed preparation companion product for grafting. The company is developing an Homecare version - VistaCare Nomad - which will bring an expert device for … Type: | 3 | 2 |
 | PRINTUP INSTITUTE Electronics printed dedicated health Printup Institute specializes in the formulation of specific inks and in printing processes. The development of the Institute is focused on health applications. It is a new technological model which aims to develop an electronic value chain printed for the health, from the biomolecular design to the supply of medical devices intended for health professionals. Within Printup Institute: . Biomolecular research and development and the design of printed sensors are provided in the Itodys laboratory of 110 people from the University of Paris Cité recognized in this sector of bioelectronics. . A Printec technological platform with … Type: | 2 | 3 |
 | SPIMA Therapeutics Unlocking New Immunotherapy Paths with Smart Peptides SPIMA Therapeutics emerges as a spin-off from the University of Montpellier, France, uniting experts in cutting-edge peptide chemistry and inflammation biology. SPIMA focuses on developing innovative peptide-based immunotherapies for challenging targets, particularly protein-protein interactions. Our lead program is a Stapled Peptide targeting the Myddosome complex. This innovative approach holds immense promise for revolutionizing treatments in inflammatory and oncological diseases, offering hope where it's needed most. SPIMA Therapeutics is part of the nexus of Landmark Bioventures. Join us in shaping the future of medicine, where discovery meets dedication. Immunothery Type: | 1 | 4 |
 | ALPHANOSOS OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is … Type: | 4 | 4 |
 | INNOVHEM Innovative science to improve the health of patients To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation. Type: | 14 | 5 |
 | Tongue Lab Better Breath, Better Sleep Our tongue says a lot about our health. Lingual dysfunctions are a major cause of problems as diverse as chronic snoring, obstructive sleep apnea (OSA), mouth breathing, malocclusion (misalignment of the teeth), bruxism (teeth grinding and jaw clenching), temporomandibular joint dysfunction and atypical swallowing. Tongue Lab created the TRP (Tongue Right Positioner), a patented, oral medical device designed to reeducate the tongue and permanently restore its physiological functions, position and muscle tone. The TRP is worn on the upper teeth while we sleep for an average of six months only. By treating the lingual dysfunctions that … Type: | 3 | 5 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: | 5 | 6 |
 | Ilasis Laser Designers of frugal ophthalmic laser solutions. Ilasis is an innovative player in medical devices by applying frugal innovation to the challenges of ophthalmology. The most advanced technologies must be made available to the greatest number of people by simplifying the devices and their use. Ilasis designs and manufactures the solution Helix, a frugal femtosecond laser for cataract surgery and capsulotomy The only system offering a flawless cutting solution, the simplicity of a non-invasive handpiece at lower cost. #medtech #medicaldevice #ophtalmology laser, ophthalmology, laser femtosecond, femtolaser, frugality, and cataract Type: | 12 | 7 |
 | UseConcept Take care of the ergonomics of health products! Specialists in the ability to use medical devices. We help you design a relevant, intuitive, safe and pleasant to use product USeconcept supports you in the management of ergonomics in the design and improvement phases of your products and services. Specializing in usage innovations, we have special expertise in medical IT, medical devices as well as new technologies related to trade. We help you better understand the needs of your users and design a complete, intuitive, safe and pleasant product. These characteristics are now increasingly required by regulations and constitute an essential … Type: | 4 | 9 |
 | Phenocell Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell has specific expertise in the production of: -human skin cells: sebocytes, melanocytes and keratinocytes -human retinal … Type: | 2 | 9 |
 | Sysark Confidence and innovation Sysark markets the first device to the world of preparation, mixture, storage and withdrawal of radio-pharmaceutical drugs at TC99m. Type: | 8 | 11 |
 | dianosic "Smartly designed for you" Dianosic ambitions to become a leading company in solving challenges in patient’s adherence to medication. We provide an alternative to daily medication by designing a unique sustained intranasal drug delivery solution for respiratory and chronic central nervous system diseases. Dianosic aims to fight against debilitating chronic diseases that affect millions of people. Our first focus is on chronic allergic rhinitis and chronic rhinosinusitis. Currently, 85% of allergic rhinitis patients are not compliant with their treatment. Furthermore, 20% to 25% of patients do not respond to first-line treatments. These medical challenges significantly impact patient’s quality of life. … Type: | 26 | 13 |
 | Minos Biosciences What You See Is What You Seq - Revolutionary cell analysis solution for fundamental, translational & pharma/biotech R&D Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics. Type: | 11 | 16 |
 | Arterya The experts in the detection of the artery Normandy start-up based in Caen, we develop Blood'Up, a medical device that allows the instant detection of arteries. Type: | 32 | 17 |
 | Eurosafe CRO Eurosafe is a sub-contract research company (CRO) certified good laboratory practices (BPL), specialized in human and veterinary pharmaceuticals, cosmetic products (ingredients and finished products), food supplements and medical devices. Depending on your products, a single contact, surrounded by scientists and regulatory experts supports you to define and carry out regulatory procedures, carry out the admit tests (absorption, distribution, metabolism and elimination), safety, tolerance or efficiency required to market your products. Eurosafe is a single CRO with multiple skills, organized around 3 complementary centers: - In vitro tests - Volunteer tests - Toxicological and regulatory expertise Eurosafe is approved for the … Type: | 6 | 17 |
 | PhinC Development 15 years of Quantitative Pharmacology Solutions applied to the development of drug candidates. PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the … Type: | 8 | 17 |
 | OrigaLys ElectroChem More than 75 years of experience in electrochemistry - Our know-how at the service of your projects OrigaLys was founded in 2010 by 4 R&D engineers from a famous French manufacturer of Potentiostat, Galvanostat and Impedance Meters EIS: Tacussel, which became after Radiometer Analytical. OrigaLys relies on more than 75 years of experience and a distribution network in more than 60 countries to offer a complete range of instruments: mono and multi potentiostats, galvanostats and impedance meters, rotating electrodes, low current probe, multiplexer, pH meters and conductivity meter. But also, accessories: electrodes (Reference, auxiliary, work, pH, ISE, conductivity cell, μ-electrodes, … Type: | 6 | 18 |
 | EVEON Transforming Patient Experience EVEON aims to become international leader in the automatic preparation and delivery of therapeutic treatments to improve patient quality of life. As a partner of healthcare players, EVEON designs and manufactures technological, digital and user innovation products and services. Forward looking, EVEON places at the heart of its commitments social values of high standards that meet the challenges of personalized and participative medicine. EVEON focuses on business partnerships with a collaborative spirit of transparency and openness. EVEON develops a strategy based on ethical values of performance and adaptability to the needs of its clients. Type: | 15 | 19 |
 | ANTABIO Developing Tomorrow's Antibacterials Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant Type: | 22 | 21 |
 | INOPROD 🇫🇷🇨🇭 Expertise and 4.0 technology at the service of your industrial performance! INOPROD - Consulting, Expertise & amp; Engineering. Inoprod helps SMEs for the innovation of their products and processes. Inoprod intervenes mainly in three areas of activity: - Product development. From the idea to industrialization, the success of the development of a product requires a methodical and structured organization. Based on industrially recognized tools, Inoprod supports its customers in their approach. - Optimization of products and process. Profitability, the watchword of any leader. In order to increase it, INOPROD provides solutions via simulation: o The dimensioning of mechanical elements by … Type: | 25 | 33 |
 | Cardiawave Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis. Innovation prize winner of many contests, Cardiawave is a clinical-stage company which develops an innovative non-invasive image-guided medical device (MD) to treat aortic valve stenosis with ultrasound technology. Aortic stenosis is a life-threatening disease which is a major public health concern in Western countries (10 million people affected). The MD uses focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. The company was created at the end of 2014 as a result of a long-term partnership between the Langevin Institute / Physics for Medicine Paris, … Type: | 28 | 30 |
 |  AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 31 |
 | Core Biogenesis The future of recombinant protein bioproduction for Regenerative Medicine & Skincare. The future of recombinant protein bioproduction. Type: | 12 | 32 |
 | Naobios Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches. Type: | 8 | 36 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 15 | 34 |
 | Theodo HealthTech Agile compliance for digital health. The world of health has known a technological revolution in recent years in recent years. Digitalization is today a major issue in the care path of patients, but also in the daily lives of health professionals. At Theodo Healthtech, we support all health players in their e-health projects! Thanks to our experience of Lean and Tech, combined with our knowledge of health, we design and develop digital medical devices that fit into the care path of patients (digital therapies - DTX, virtualized clinical trials, digitalized care path). In the design of these products, we also … Type: | 10 | 42 |
 | Selenium Medical Intuitive Innovation for Infection Prevention We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box thanks to our specialization and expertise in the medical industry. We can offer you our know-how, specific skills and expertise in technical consultancy for your projects in clean room injection, surface treatment and sterile packaging of your medical devices, through our different divisions SELENIUM Injection, SELENIUM Surface Treatment and SELENIUM Packaging. In all our divisions, … Type: | 12 | 49 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing Tags: FrenchTech2030 Type: | 15 | 57 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. We leverage our technologies and expertise to advance 7 fully owned drug discovery programs focusing on cancer resistance and escapement, a growing concern in aging populations, and chronic inflammatory diseases. We also co-develop programs with academia and pharmaceutical partners. Our proprietary ATLAS drug discovery platform unites our technologies based on 30 years of research from renowned scientists and founders, Louis Lagardère (Sorbonne University and CNRS), Matthieu Montes (CNAM), Jean-Philip Piquemal (Sorbonne … Tags: FrenchTech2030 Type: | 60 | 68 |
 | IHU LIRYC - Heart rhythm disease Institute 🔬 Liryc is an international research, clinical and teaching centre focusing on heart rhythm diseases. The Heart Rhythm Disease Institute (French: L'Institut des maladies du RYthme Cardiaque), is one of 6 French university hospital institutions created in 2011 as part of the investments in the future program ("Investissements d'avenir") to boost medical research and innovation. This institute, created by Professor Michel Haissaguerre along with cardiology teams of the University Hospital of Bordeaux, unites multiple specialties around cardiac electrophysiology from research on ionic channels (microgenerators producing electric flows in cells) to whole heart and patient care. LIRYC is a basic research, … Type: | 33 | 112 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 129 |
 | The American Academy of Anti-Aging Medicine (A4M) Redefining Medicine A4M is dedicated to the advancement of tools, technology, and transformations in healthcare that can detect, prevent, and treat age-related diseases. A4M further promotes the research of practices and protocols that have the potential to optimize the human aging process. The organization is also dedicated to educating healthcare professionals and practitioners, scientists, and members of the public on biomedical sciences, breaking technologies, and issues related to the anti-aging industry. Our mission is to redefine modern medicine by providing clinicians with the education and resources needed to provide whole person care that optimizes healthspan and vitality for patients worldwide. … Type: | 2 | 72 |
 | CELLINK Create the future of health CELLINK is proud to be part of BICO. BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,900 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm … Type: | 20 | 98 |
 | BMG The Federal Ministry of Health uses this channel to inform you about current health policy projects and laws. You can find more information on the pages of the authorities of our division 👇 Current topics of the BMG: www.gesundheitsministerium.de Health promotion and prevention: www.bzga.de Infectious diseases: www.infectionsschutz.de Disease surveillance and prevention: www.rki.de Vaccines and biomedical drugs: www.pei.de Medicines and medical products: www.bfarm.de You will also find our netiquette and imprint here: Netiquette: https://www.bundesgesundheitsministerium.de/social-media-netiquette.html Imprint: https://www.bundesgesundheitsministerium.de//impressum Type: | 26 | 197 |
 | Biotech Primer Expert-Led Life Sciences Training and Certifications for Non-Scientists to Advance Your Career Biotech Primer’s mission is to provide high-quality educational resources to professionals in the life sciences sector, focusing on the unique needs of non-scientists. With over 150,000 professionals trained since its founding in 2001, we offer a wide range of specialized courses that cover essential topics such as drug development, biotech business strategies, medical device development, and biotech manufacturing processes. Our programs are designed to make complex scientific concepts accessible, empowering professionals to understand the intricacies of the life sciences industry and excel in their roles. Biotech Primer’s courses … Type: | 1 | 9 |
 | AXIENCE S.A.S. Axience was created in 2001 and became a veterinary pharmaceutical operator in 2005. Portfolio of drugs, princeps and generics, intended for pets, equine, cattle and pigs Very high specialization in hygiene and disinfection of veterinary clinics since 2003 and in anesthesia and analgesia all species since 2009. Anesthesia, disinfection, veterinary biocides, and analgesia Type: | 0 | 51 |
 | Theraclion Creators of extracorporeal robotic treatment platforms Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound. High Intensity Focused Ultrasound (HIFU) does not require incisions nor an operating room, leaves no scars, and allows patients an immediate return to their daily activities. Echotherapy, as the HIFU treatment method is called, concentrates therapeutic ultrasounds to an internal focal point from outside of the body. Theraclion has developed two CE-marked robotic platforms delivering echotherapy: SONOVEIN® for varicose veins and ECHOPULSE® for breast fibroadenoma and thyroid nodules. Each representing the potential to … Type: | 2 | 35 |
 | SIFI Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. Eye Care, Pharmaceutical/Nutraceuticals/Medical Devices, Surgical & Diagnostic Medical Devices., Ophthalmology , Science, Researchers , Research, Vision, Eyes, Surgical, Medical technology, Health, Medicine , Eye health , and Biotech Type: | 2 | 616 |
 | PHAXIAM Therapeutics Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris … Type: | 20 | 85 |
 | Innate Pharma Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical … Type: | 26 | 196 |
 | Centre Médical Germaine REVEL Establishment of excellence expert in the SMR management of neurological conditions The Germaine Revel Medical Center (CMGR) is an ESPIC of medical care and rehabilitation (SMR) specialized in the ailment of the nervous system, managed by the Germaine Revel foundation. It is located in a green setting in the Monts du Lyonnais in Chabanière (69440) halfway between Lyon and Saint-Etienne. Its hospital capacity is 83 beds and places made up of full and week hospital units, a day hospital, a respite unit (SLA) as well as 8 beds dedicated to EVC-EPR patients. Each year, more than 800 patients suffering from … Type: | 0 | 47 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 18 |
 | BIOGARAN The box that takes care of yourself. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new market that is still unknown: generic drugs. Offering patients with recognized quality drugs whose patent fell into the public domain then was a new type of know-how that traditional laboratories did not have. Our know-how is available through different ranges: small everyday ailments with the Biogaran Conseil® range, to heavier pathologies with prescription drugs. Whatever pathology, patient health is at the heart of biogaran concerns and the same rigor is brought to the development of … Type: | 10 | 546 |
 | CardiaTec Bio Decoding cardiovascular disease biology for novel therapeutic discovery CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. We leverage large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics. Type: | 6 | 12 |
 | CorFlow CorFlow is developing a system that will be the first to detect & treat microvascular obstruction (MVO) in real time. CorFlow was founded on the belief that current PCI and cardiac care remains suboptimal due the fact that underlying microvascular dysfunction and obstruction is not detected and treated adequately. CorFlow believes, like much of the medical community, that the next frontier of innovation and positive impact on clinical outcomes in cardiology and beyond will come from the microvascular space. Our first solution is a system that will be the first to diagnose microvascular obstruction (MVO) in real time during PCI … Type: | 0 | 21 |
 | MedLumics, S.L. MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare Cardiology Type: | 0 | 27 |
 | PL BioScience GmbH Changing cell culture with animal-free cell growth promoters We at PL BioScience are experts in cell culture supplements derived from human Platelets. Our mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREMTM. The ELAREMTM Platform unites tailored cell culture supplements based on Human Platelet Lysate. The human origin combined with a rich growth factor content not only supports cell growth, but also enables various applications: The products cover all needs of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from lab to patients … Type: | 0 | 25 |
 | ILYA Pharma Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients ATMP, Gene Therapy, Biologics, Drug development, Clinical trials, GMP, Growth, H2020, Uppsala, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, Cutting edge, and IBD Type: | 8 | 14 |
 | HepatoChem Reinventing Chemistry for Life Sciences The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008 Metabolite synthesis, photochemistry, research instrument, and photoreactor Type: | 0 | 8 |
 | Dynamic42 GmbH Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies Type: | 1 | 22 |
 | Cytochroma Accelerating global drug development Cytochroma predict how drugs will react in a global population in health or disease. Our unique, ethnically diverse library of iPSC and automated cell culture generates robust, reliable, mature hepatocytes for toxicity testing. We are supporting life science companies, de-risking safe compounds prior to clinical testing, making new drug development faster, safer and more efficient. toxicity testing, liver specialists, hepatocyte testing, disease models, high throughput, high content screening, iPSC, automated manufacture, machine learning, artificial intelligence, predictive testing, and pre clinical testing Type: | 2 | 4 |
 | Eat Just, Inc. Our mission is to build a food system where everyone eats well. Eat Just is a food technology company with a mission to build a healthier, safer and more sustainable food system in our lifetimes. The company’s expertise, from functionalizing plant proteins to culturing animal cells, is powered by a world-class team of scientists and chefs spanning more than a dozen research disciplines. Eat Just created America’s fastest-growing egg brand, which is made entirely of plants, and the world’s first-to-market meat made from animal cells instead of slaughtered livestock. food science, food, science, culinary, food production, vegan, vegetarian, cultured meat, … Type: | 12 | 265 |
 | Dosepharma DosePharma, the Blistering provider of pharmacists. Founded in 2013, DosePharma specializes in the packaging of drugs (Blistering). Certified by Swissmedic, our company is distinguished by the personalized and high quality Blistring services proposal. In our laboratory, the doses of personalized drugs are put in robotic, highly controlled and respecting the highest safety standards. We work on a daily basis in order to relieve patients in their medication and allow pharmacists to benefit from a tailor -made service for their patients. Technology, automation, medication, digital, pharmacy, IT, Challenger Mindset, and sales per unit Type: | 0 | 13 |
 | CRISPR Therapeutics Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients … Type: | 12 | 442 |
 | COAT-X We are leader for the ultra-hermetic encapsulation of electronics with parylene-based multilayer barrier coating. We are a Swiss company created in 2016 by experts in thin film technology and medical devices. Since 2024 COAT-X is part of the Plasmalex group of companies, together with Europlasma, CPI and Spoolex. We offer job coating service and deposition systems for parylene-based barrier coating. Our unique Parylene multilayer technology protects sensitive industrial and implantable electronics for the very long-term. Under ISO 13485 certification, in clean room and with our proprietary chemical vapor deposition machines, we offer premium coating service to legal and contract medical … Type: | 6 | 13 |
 | CleanSlate UV CleanSlate UV is a biosafety company creating the next generation of intelligent sanitization solutions. CleanSlate UV is a biosafety company creating the next generation of intelligent sanitization solutions. We leverage the power of UV-C light to kill the most dangerous bacteria and viruses without damaging devices. With a focus on rigorously tested and intuitive products, CleanSlate UV is trusted by world-class facilities, from hospitals to five-star hotels. Ultra-violet light, Healthcare, Mobile device disinfection, Smartphone sanitizer, Food processing, Food safety and quality control, Medical Devices, uv light, and infection control Type: | 2 | 1 |
 | Civilization Ventures Early-stage life sciences investment firm supporting category-defining technologies in healthcare At CV, we champion visionary founders tackling the most critical challenges in biology and healthcare. With a portfolio worth $9.7B, encompassing 64 companies and 9 successful exits, we provide the capital and resources necessary for innovators to thrive. Type: | 25 | 10 |
 | Brave Health Taking control of your mental health? Now that's Brave. Brave Health provides telehealth-enabled mental health care services including individual therapy, psychiatry and medication management, marriage and family counseling, clinician-led group therapy and specialized therapeutic programs. We are in-network with more than 200 insurance plans, including commercial, Medicaid and Medicare. mental health, behavioral health, community health, telehealth, addiction, psychiatry, community mental health, telemedicine, Socialwork, casemanagement, healthandwellness, medicationmanagement, digitalage, techsavvy, technologybased, and healthcare Type: | 10 | 208 |
 | Uluu From the ocean, for the planet Uluu is an exciting new biomaterial that's incredible for our oceans and climate. It fights global warming by sequestering carbon in anything, and everything, that's built with it. It's biodegradable - so it won't harm our environment or the creatures living in it. And, it's made from seaweed - an amazing, renewable resource, which cleans up our oceans, promotes marine biodiversity, yet doesn’t displace precious farmland. Uluu - reviving the world. Type: | 7 | 17 |
 | Amino Labs Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education Type: | 3 | 2 |
 | Institut Carnot CALYM Consortium dedicated to partnership-based research on lymphomas CALYM is a consortium of organisations dedicated to lymphoma research, acknowledged as “Carnot Institute” since 2011: these are public/parapublic research institutes strongly committed to developing partnership-based research with the socio-economical sphere. CALYM was born from the wish shared by several research organisations to create a Consortium for the Acceleration of innovation and its transfer in the field of LYMphoma research. It currently includes 20 organisations with complementary expertise in preclinical, translational and clinical lymphoma research: 2 non-profit associations: – The Lymphoma Study Association (LYSA), a cooperating group that is the international leader of … Type: | 23 | 26 |
 | SGH Medical Pharma Your pharmaceutical industry’s partner, from OEM subcontracting to the design & manufacture of injected medical devices. SGH Medical Pharma results from the alliance of 3 plastic processing companies with a solid reputation of 30 years of know-how (Rovipharm, Eskiss, Stiplastics). The different facilities are certified ISO 13485, including clean rooms The SGH Medical Pharma group designs and produces innovative solutions for : - Drug and supplement administration for solid and liquid medicines : dosing syringes, measuring cups and spoons, single doses, pipettes for droppers and pill dispensers... - Pharmaceutical use : plunger for pre-filled syringes, pre-filled syringes... - IV diagnostics … Type: | 4 | 114 |
 | Sunogel Inc Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration. Type: | 0 | 1 |
 | UMR Right We are an immunology lab pursuing innovative ways to control cancer as well as inflammation in diseases and graft. UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comté. We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI). Our main goals: - Characterize the pathogenic or protective immune responses involved in these diseases in order to identify … Type: | 9 | 45 |
 | Inside Therapeutics (InsideTx) Revolutionizing nanoparticle and RNA-LNP formulation with innovative microfluidic-based systems! At InsideTx we’re transforming nanoparticle manufacturing to release the full power of RNA-LNP therapeutics and nanomedicines. By merging microfluidics and biotechnology, we deliver a comprehensive, end-to-end nanoparticle formulation solution that streamlines your path from screening to production. First, meet TAMARA—our all-in-one R&D platform that eliminates losses, leverages reusable microfluidic chips, and supports every phase of development, from initial screening to in-vivo studies. It’s the ultimate solution for RNA-LNP and nanomedicine research—and our users say it best: “I’m absolutely blown away by how user-friendly, efficient, and straightforward this system is!” But that’s … Type: | 20 | 15 |
 | ENDODIAG Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients worldwide!). Located in Evry, France, within Genopole, the French largest Biocluster, the company leverages the experience of its scientific cofounders who have been working in this field for over 20 years and a network of major hospital centres both in France and abroad. Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes … Type: | 8 | 5 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 170 |
 | PathoQuest A global CRO providing BioPharma Quality Control Testing based on Next Generation Sequencing PathoQuest is a global CRO providing NGS-based Quality Control testing through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients. Validated and accepted GMP assays for viral safety and genetic characterization of raw materials, cell and gene therapies, mAbs & vaccines. Testing available in Paris (France) and in Wayne PA. Biologics Testing, Biosafety Testing, Biologics Quality Testing, Biologics QC based on Next Generation Sequencing (NGS), Viral Safety, Genetic Characterization, Testing for Clone selection, Genetic Stability Testing, Release Testing for Biologics, and Biologics … Type: | 1 | 58 |
 | AXELIFE Expertise - Prevention - Innovation Axelife is a 100% French medtech specialized in the field of cardiovascular risk assessment and prevention. We design and develop evaluation and prevention solutions, our first medical device: the popmeter, makes it possible to measure the wave speed of Gold Standard pulse of the measurement of arterial rigidity. The DM is class IIA and the company is ISO 13485. Our scientific team works on algorithms to calculate arterial age and participated in the publication of more than 30 scientific publications which supported the interest in the measurement of arterial rigidity. Type: | 46 | 13 |
 | POLYVALAN Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design Type: | 2 | 3 |
 | NMR - Bio Your partner for innovation NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation). Type: | 1 | 2 |
 | Biossan your partner for preclinical research Biossan : A French CRO dedicated to biomedical research Biossan helps its academic and industrial partners develop their innovations by performing preclinical trials under controlled conditions. Biossan specializes in evaluating medical devices, new techniques, and pharmaceutical products in healthy and pathological models. Conduite et accompagnement de projet de recherche, Organisation de formation, and Bien-être et expérimentation animale Type: | 1 | 1 |
 | Athana Relief of heat puffs by cryotherapy Athana is a french start-up specializing in the commercialization of innovative solutions for women's natural well-being, Particularly for those suffering from the effects of menopause. We focus on improving quality of life by offering natural and effective alternatives to hormonal treatments, which are often associated with health risks. Our mission is to alleviate hot flashes, the most debilitating symptom of menopause, Affting 900 million Women Worldwide. To add this need, we have developed Two Flagship Products: Hera, a Portable Device That Uses Cryotherapy to Provid Instant Relief from Hot Flashes, and Moona, A Connected … Type: | 11 | 9 |
 | IMD-Pharma SAS Rebalancing the immune system, resolving inflammation. Drug candidates from our molecular platforms normalize the immune system by downregulating pro-inflammatory immune response and upregulating regulatory immune response. IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases. Founded in 2016, IMD-Pharma is a company from the Laboratoire de Chimie de Coordination (CNRS) and the Centre de Physiopathologie de Toulouse Purpan (INSERM/CNRS/Université Toulouse III). immuno-modulation, anti-inflammatory drugs, chronic inflammatory diseases, Multiple Sclerosis, Rheumatoid Arthritis, dendrimers, monocyte rehabilitation, and psoriasis Type: | 1 | 7 |
 | MaaT Pharma Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed … Type: | 36 | 88 |
 | iThylo iThylo supports companies on all alcohol issues : prevention, screening, follow-up iThylo is the first connected ethylotest. For professionals, it allows companies to ensure that their employees are able to work in the best possible conditions. The iThylo team's mission is to manage risks in companies. To contact us hello@ithylo.com Informatique, Objets connectés, Securité, Prévention, Pilotage des risques, Ethylotest connecté, Accompagnement, medtech, Dispositifs Médicaux connectés, dépistage, alcool, alcohol, drogue, and drug Type: | 7 | 23 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 17 | 82 |
 | Institut for Regenerative Medecine & Biothérapies (IRMB) Our mission is to change human health through a deep understanding of immune cells and stem cells biology.. Type: | 2 | 3 |
 | Tristel Global We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business. Our mission is most relevant to hospitals where the risks of infection to individuals are highest. We have two key areas of focus in the hospital: i) the high-level disinfection of … Type: | 2 | 156 |
 | Cynata Therapeutics A Next Generation Stem Cell Therapeutics Company Cynata Therapeutics Limited (ASX: CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on CymerusTM, a proprietary therapeutic stem cell platform technology. CymerusTM overcomes the challenges of other production methods by using induced pluripotent stem cells (iPSCs) and a precursor cell known as mesenchymoangioblast (MCA) to achieve economic manufacture of cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale without the limitation of multiple donors. Cynata’s lead product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for … Type: | 3 | 11 |
 | Bactiguard AB Bactiguard is a global innovative medtech company with Swedish roots and a purpose to prevent infections. Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention technology and solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard operates through license partnerships with leading global MedTech companies that apply … Type: | 5 | 98 |
 | Freenome Outpacing cancer starts with early detection Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ … Type: | 12 | 415 |
 | Cleara Biotech B.V. Targeting cellular senescence to extend human healthspan at old age and to counteract late stage cancer Cleara is a biopharmaceutical R&D company dedicated to discovery and development of therapies against cancer and chronic diseases through selective elimination of subtypes of cellular senescence. Through detailed understanding of the molecular and biological pathways that underlie these individual pathological phenotypes, we set up disruptive, innovative and proprietary platform technology to design and optimize (peptide-based) therapeutics that exploit their weak spots for safe and selective clearance. Cleara’s lead FOXO4 program is focused on generation of disruptive and proprietary technology against “scarred” cellular senescence for … Type: | 1 | 16 |
 | CenterWatch, A WCG Company The Trusted Source for Clinical Trial Information Since 1994, CenterWatch, A WCG Company has been the recognized global leader in providing clinical trials information to professionals working at sponsors, CROs, research sites and niche service providers. Today, WCG CenterWatch delivers critical industry insights to 150,000 life science executives every week through its newsletters, conferences, webinars, books, in-depth market surveys, industry profiles and clinical databases. And millions of patients and caregivers start their search for clinical trials with CenterWatch, with one of the largest clinical trial databases on the internet, CenterWatch iConnect. Clinical Trials Information, FDA Drugs Information, Clinical Research Market … Type: | 3 | 11 |
 | Cast21 Elevating the way the world heals through our waterproof cast and brace alternatives for the 21 Century. Cast21 is a medical device company that creates innovative healthcare solutions, inspiring change in the way the world heals. Our first product offers a waterproof alternative to casting or bracing for the treatment of bone fractures or joint injuries. This alternative improves the quality of life of patients through its breathable and lightweight design. Doctors benefit from a streamlined application and removal process that does not require any scanning or sawing equipment, heat, water, or electricity. We are registered and listed with the … Type: | 4 | 12 |
 | Harmonic Drive LLC Precision Motion Control Gears and Actuators Harmonic Drive LLC designs and manufactures precision servo actuators, gearheads and gear component sets. We work with industry-leading customers and companies of all sizes to provide both standard product and, in most cases, custom-engineered solutions. Harmonic Drive LLC provides high precision, high performance products to meet customer’s mission critical application requirements. With over 50 years of experience, our expert engineering and production teams continually develop enabling technologies for the evolving motion control market. Sales Offices in Long Island, NY, Chicago, IL and San Jose, CA are staffed with degreed sales engineers, available to assist … Type: | 20 | 118 |
 | SureCall Cell Phone Signal Boosters to Raise Your Bars SureCall® specializes in the design and manufacture of cell phone signal boosters, antennas and accessories. Our signal boosters dramatically improve cellular reception for homes, businesses, vehicles and watercraft. Our flagship product line of FCC-approved cell phone signal boosters enhance the range and reception for all North American cellular carriers, including voice, text and 4G LTE data. Founded in 2001 and based in the Silicon Valley California, SureCall is the cell phone signal booster leader in combining high quality technology with innovative designs, producing award-winning boosters that dramatically improve cell phone reception. With … Type: | 6 | 50 |
 | Sutro Biopharma, Inc. Changing the future of Oncology Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro is advancing a robust early-stage pipeline of novel exatecan and dual-payload antibody drug conjugates (ADCs), coupled with high-value collaborations and industry partnerships, which validate its continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com. Type: | 9 | 319 |
 | Exagen Inc. A patient focused, discovery driven life science company. Exagen Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our AVISE tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on our company, please visit www.Exagen.com. For more information on AVISE testing services, please visit www.AviseTest.com. Read our Social Media Terms of Use here: http://bit.ly/smtou Diagnostic Testing, Prognostic Testing, Therapeutic Drug Monitoring, and … Type: | 2 | 207 |
 | Research!America: Discovery. Innovation. Health. The Research!America alliance advocates for science, discovery and innovation to achieve better health for all. The Research!America alliance advocates for science, discovery, and innovation to achieve better health for all. We urge Congress and the administration to increase funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA) and National Science Foundation (NSF) at levels that keep pace with scientific opportunity. We also advocate for federal funding for global health research and a legislative and regulatory climate that stimulates growth in private sector … Type: | 8 | 55 |
 | J. Craig Venter Institute Pioneering Genomics to Positively Impact Life JCVI is a premier, not-for-profit genomics research institute with more than 120 scientists and staff in Rockville, Maryland and San Diego, California. JCVI continues to lead the world in genomic science with programs focused on genomic medicine, infectious disease, microbial and environmental genomics, synthetic biology, and informatics. Please visit our web site at www.jcvi.org Genomic Research, Genomic Medicine, Bioinfomatics, Infectious Disease Research, Life Sciences, Mammalian Genomics, Microbial & Environmental Genomics, Infectious Diseases, Synthetic Biology, Bioenergy, Microbial Pathogenesis, Viral Genomics, Bioinformatics, and Informatics Type: | 12 | 196 |
 | National Comprehensive Cancer Network® (NCCN®) An alliance of leading cancer centers devoted to patient care, research, and education. The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and … Type: | 7 | 239 |
Startup